Cardiovascular risk: its assessment in clinical practice

被引:0
|
作者
Wilson, SL
Poulter, NR
机构
[1] Barts & London Hosp, William Harvey Res Inst, London EC1M 6BQ, England
[2] Imperial Coll Sch Med, Dept Clin Pharmacol, Cardiovasc Studies Unit, London W2 1PG, England
关键词
cardiovascular system; Framingham equation; risk assessment; risk factors;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Cardiovascular disease is one of the major causes of mortality and morbidity in Western industrialised countries. Many factors impact on the likelihood of an individual suffering a stroke or heart attack. One of the greatest challenges facing clinicians today is how best to identify those individuals at increased risk, to prevent them becoming tomorrow's patients. Risk assessment tools can provide useful frameworks to support the identification of individuals who may benefit from therapeutic intervention: however, such tools should be used with care, as they do not include all the factors that contribute to future disease risk, and they are subject to an age bias. Nonetheless, they provide a systematic, evidence-based approach to the delivery of preventative healthcare services.
引用
收藏
页码:248 / 251
页数:4
相关论文
共 50 条
  • [1] Tools for cardiovascular risk assessment in clinical practice
    Cainzos-Achirica M.
    Eissler K.
    Blaha M.J.
    Blumenthal R.S.
    Martin S.S.
    Current Cardiovascular Risk Reports, 2015, 9 (6)
  • [2] Assessment of homocysteine as a cardiovascular risk factor in clinical practice
    Clarke, R
    Stansbie, D
    ANNALS OF CLINICAL BIOCHEMISTRY, 2001, 38 : 624 - 632
  • [3] The Challenges and Benefits of Cardiovascular Risk Assessment in Clinical Practice
    Grover, Steven A.
    Lowensteyn, Ilka
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (04) : 481 - 487
  • [4] Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice
    Law, Tamryn K.
    Yan, Andrew T.
    Gupta, Aanika
    Kajil, Mahesh
    Tsigoulis, Michelle
    Singh, Narendra
    Verma, Subodh
    Gupta, Milan
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2015, 1 (01) : 31 - 36
  • [5] RISK FACTOR ASSESSMENT FOR THE PREVENTION OF PREMATURE CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE
    Halcox, Julian P.
    Gollop, Nicholas D.
    Lacey, Arron S.
    King, William H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1432 - E1432
  • [6] Risk factor assessment for the prevention of premature cardiovascular disease in clinical practice
    Gollop, N. D.
    Lacey, A. S.
    King, W. H.
    Halcox, J. H.
    EUROPEAN HEART JOURNAL, 2012, 33 : 122 - 123
  • [7] Novel cardiovascular risk-assessment metrics and absolute risk assessment: future role in clinical practice?
    Kalhan, Atul
    Rees, Alan
    CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (04) : 321 - 323
  • [8] Cardiovascular risk assessment in the family practice
    Herrmann, M
    Segebrecht, S
    Welke, J
    Schwantes, U
    GESUNDHEITSWESEN, 2004, 66 (8-9) : 582 - 582
  • [9] Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice
    Semb, Anne Grete
    Rollefstad, Silvia
    van Riel, Piet
    Kitas, George D.
    Matteson, Eric L.
    Gabriel, Sherine E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) : 1284 - 1288
  • [10] Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools
    Kirby, M.
    Machen, I.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (12) : 1683 - 1692